Board Meeting12 Aug 2026, 05:21 pm
Mangalam Drugs Board Approves Un-Audited Financial Results
AI Summary
Mangalam Drugs & Organics Ltd announced that its Board of Directors, in a meeting held on August 12, 2026, approved the Un-Audited Financial Results (Standalone & Consolidated) for the quarter ended June 30, 2026. The company also declared that the statutory auditors have not expressed any modified opinions in their Limited Review Reports. Additionally, the board approved the appointment of M/s L.N. Joshi & Co. as Secretarial Auditors and M/s SN. Nanda & Co. as Statutory Auditors for a five-year term, subject to shareholder approval.
Key Highlights
- Board approved Un-Audited Financial Results for Q1 FY27.
- Results are Standalone and Consolidated.
- Statutory auditors issued a Limited Review Report without modified opinions.
- Appointment of Secretarial and Statutory Auditors approved.
- Auditor appointments are for a five-year term, pending member approval.
Price Impact
More from MANGALAM